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Bacteriophage therapy has demonstrated promising results towards the control of bacterial 
infections within the aquaculture industry as an alternative therapy to antibiotics. This current 
research describes the efficacy of bacteriophage therapy in controlling vibriosis within 
abalone (Haliotis laevigata). Two bacteriophages were isolated and used in in vitro assays to 
determine the effect of each specific phage on the growth of specific Vibrio harveyi isolates. 
To demonstrate efficacy, an in vivo bioassay was performed using abalone (H. laevigata) at a 
water temperature of 24 °C. Characterisation of the two isolated phages revealed they were 


















different Vibrio harveyi isolates in the in vitro assays and the bioassay demonstrated 
improved survival of abalone treated with bacteriophage. The results of the bioassay showed 
that the negative control and phage control were statistically identical, with 100% survival, 
but they were different from the positive bacterial control, with a 0% survival. The bacteria + 
phage treated group showed increased accumulative survival of 70% compared to the positive 
control. This is the first study to demonstrate the efficacy of bacteriophage therapy treatment 
for abalone. The study demonstrates that if abalones are treated with bacteriophage shortly 
after Vibrio harveyi infection, the accumulative survival could be significantly increased.  
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Highlights of the manuscript 
This research demonstrates for the first time that bacteriophage therapy can control bacterial 
infections in abalone. The positive results indicate that the therapy is effective, which enables 






















As most commercial land-based abalone farms are intensive systems (Handlinger et al. 2005, 
Stone et al. 2014), the industry is under high risk of mass mortality when the animals are 
exposed to infectious agents or the culture conditions are undesirable (Cardinaud et al. 2014b). 
Common pathogens, which cause serious infections in intensive abalone production systems 
includes viruses, bacteria, and parasites. (Vandepeer 2006, Liggins et al. 2010, Mayfield et al. 
2011).  
Vibriosis is one of the primary bacterial diseases in the aquaculture industry. This disease is 
caused by a range of Vibrio species, which can lead to mass mortality in a relatively short 
time (Jiang et al. 2013). Vibriosis-associated mass mortalities in abalone have been reported 
in France (Travers et al. 2008b, Pichon et al. 2013, Cardinaud et al. 2014a, Meistertzheim et 
al. 2014), Australia (Handlinger et al. 2005, Travers et al. 2009b, Dang et al. 2012, Stone et al. 
2014), and Japan (Travers et al. 2009b). Abalone vibriosis usually occurs when animals are 
immunosuppressed due to conditions such as elevated water temperature or spawning (Pichon 
et al. 2013, Cardinaud et al. 2014a). During the summer period, when the water temperatures 
are above 23 °C, there have been mass mortalities on commercial farms, referred to as 
summer mortality in abalones (Travers et al. 2008b, Lange et al. 2014, Stone et al. 2014). 
Previous studies showed that individual abalone undergoing gonad development are more 
susceptible to vibriosis, while immature abalone are more resistant to natural infection 
(Travers et al. 2009a, Meistertzheim et al. 2014). Since controlling water temperature on 
farms during such elevated temperatures is impractical for long periods of time, there is an 
industry need for effective vibriosis treatments for mature abalone.  
Antibiotics have traditionally been used in the treatment of bacterial diseases in aquaculture 
species (Defoirdt et al. 2007, Karunasagar et al. 2007); however, the efficacy of antibiotics is 
decreasing due to increasing rates of antimicrobial bacterial resistance. In some countries, 
antibiotics have been banned as the residues pose a threat to human health and the 


















2014). Alternative control methods are required by the seafood industry to reduce mortality 
and minimize the impact on human health and the environment. Consequently, bacteriophage 
(phage) therapy is considered one such potential alternative treatment (Karunasagar et al. 
2007, Crothers-Stomps et al. 2010, Phumkhachorn & Rattanachaikunsopon 2010, Silva et al. 
2014b). 
Phage therapy has been applied as a treatment for vibriosis within the seafood industry 
(Defoirdt et al. 2011). There are reports of phage application involving live animals such as 
post larvae prawns (Karunasagar et al. 2007), oysters (Pelon et al. 2005, Rong et al. 2014), 
fish larvae production (Silva et al. 2014b), and Atlantic salmon (Higuera et al. 2013), however, 
there are no published studies to determine if abalone can be effectively treated using the 
therapy. Phage therapy has also been used for seafood processing, for example, as surface 
treatment of channel catfish and raw salmon fillets (Soni & Nannapaneni 2010, Soni et al. 
2010), and raw oysters (Jun et al. 2014a). There is a single report of a wild type phage 
association with black abalone (Haliotis cracherodii), providing protection from the 
rickettsial withering syndrome (Stobart et al. 2012), which is associated with intracytoplasmic 
rickettsia-like organisms (Friedman et al. 2014). Friedman and colleagues (2014) showed that 
the presence of natural phages reduced mortality in abalone populations, but they did not 
apply phage as a therapy. Yu et al. (2013) isolated and characterized five lytic phages from an 
abalone farm and found there was potential to apply phage therapy for controlling V. owensii 
induced vibriosis in abalone. However, there are no further studies attempting to use the 
selected phages as treatment for abalone vibriosis. 
This study aimed to determine whether bacteriophage therapy could be used to control 
bacterial diseases in greenlip abalone (Haliotis laevigata) using V. harveyi as an infection 
model. The hypotheses of this study were that phage(s) will inhibit or decrease the growth of 
the model bacteria in vitro, and selected phage(s) can be used to control vibriosis in abalone. 
 


















2.1 Vibrio harveyi strains 
All isolates were from the School of Animal and Veterinary Sciences culture collection at the 
University of Adelaide, Roseworthy campus. The isolate used in the abalone bioassay was 
collected from oysters in Shark Bay, West Australia.  
The Vibrio strains, which were used to amplify bacteriophages, were propagated using 
bacteriological peptone, yeast, sea salt (PYSS) agar plates (5 g bacterial peptone, 1 g yeast 
extract, 33 g synthetic sea salt, and 15 g agar per liter), incubated at 28 °C overnight and 
checked for purity by visualization of a pure culture. A single colony of each bacterial isolate 
was transferred into 10 mL of PYSS broth to enable propagation of phages.  
 
2.2 Determining cell optical density 
The method of determining the correlation of cell density and optical density (O.D.) was 
adapted from Brown (2012). Briefly, a stab inoculation of strain MO10 was incubated in 10 
mL of PYSS broth (5 g bacterial peptone, 1 g yeast extract, and 33 g synthetic sea salt per 
liter) at 28 °C overnight. One milliliter of culture was transferred into 9 mL of PYSS and the 
absorbance (A) was measured with a spectrophotometer at a wavelength of 600 nm (BIO-
RAD xMark
TM
 Microplate Spectrophotometer SW MPM6). The culture was incubated at 
28 °C shaking at 440 rpm until it reached optical density at A600 approximately 0.2, 0.4, 0.6, 





. From each dilution, 100 μL of the aliquot was spread onto a PYSS agar 
plate, and incubated at 28 °C overnight. Plates with 30 to 300 colonies were selected, and 
colonies were counted. The original colony forming unit (cfu·mL
-1
) was determined  
 
2.3 Prophage detection  
All bacterial isolates were transferred individually into 10 mL PYSS broth by stab 


















These culture broths were used to prepare a 96-well Mitomycin C (MMC) assay. Control 





; and 200 ng·mL
-1 
of MMC respectively for each bacterial 
strain. Each microtiter well contained a total volume of 200 μL. Each sample was tested in 
triplicate within each group for each strain. All other blank wells were filled with 200 μL 
PYSS broth. Growth profiles of each well were determined by measuring the optical density 
every 5 minutes over an 18-hour period (BIO-RAD xMark™ Microplate Spectrophotometer 
SW MPM6). Optical density curves were generated for each well and were compared with the 
control groups to determine the presence of a prophage. 
 
2.4 Source of bacteriophages and abalones 
Hatchery water from the South Australia Research and Development Institute (SARDI) 
Aquatic Sciences (2 Hamra Avenue, West Beach, SA, 5024) and oyster tissue obtained from 
the Veterinary Diagnostic Laboratory (VDL), The University of Adelaide were used to isolate 
bacteriophages capable of lysing the V. harveyi cultures. There were 5 water samples and 8 
oyster tissue samples. 
Eighteen-month-old abalones (weight = 18.7 ± 0.8 g) were sourced from SARDI Aquatic 
Sciences and were transported to the South Australian Aquatic Biosecurity Centre at the 
University of Adelaide, School of Animal and Veterinary Sciences. The water temperature 
was raised by 2 °C per day from 18 
o
C until the final temperature was 24 
o
C. During that time, 
abalones were fed a commercial abalone feed (Aquafeeds Australia PTY LTD).  
 
2.5 Bacteriophage isolation  
To isolate bacteriophages, 50 mL of water or tissue sample liquid and 1-2 mL of overnight 
bacterial culture were added to 50 mL of double concentrated PYSS broth for each strain, 
shaking at 50 rpm overnight at 28 °C. The broth mixture was then centrifuged at 10,000 × g 


















of filtered supernatant was transferred onto the centre of a lawn plate using the initial host 
strain of bacteria and incubated at 28 °C. Phage plaques were visualized the following day. 
Phage plaques (with agar) were removed from the lawn plate and dissolved into 1 mL SM 
buffer (100 mM NaCl, 8 mM MgSO4, 50 mM 1M Tris-HCL pH=7.5, 0.01% (w/v) gelatin) for 
approximately 2 hours at room temperature. The resulting solution was filtered with a 0.45 
μm syringe filter. A 1:10 serial dilution of the filtered solution was then prepared with PYSS 




 of the original 
phage aliquot. Twenty microliters of each diluted phage aliquot was transferred onto the same 
strain bacterial lawn that was used for isolating this phage. The plates were incubated at 28 °C 
overnight. New plaques with the least concentration of phage were removed and re-purified 
three times to ensure purity with the final plaque stored in SM buffer. 
 
2.6 Bacteriophage propagation  
The bacteriophages were propagated in overnight cultures of bacterial isolates, from which 
the phage was originally amplified. Phage isolates were mixed with bacterial isolates with an 
O.D. of 0.2 (v/v). The mixture was inverted and incubated for 5 minutes at room temperature, 
and then used to make lawn culture and incubated at 28 °C overnight. Ten mL of SM buffer 
was added onto each lawn, exhibiting approximately 100% clearance, for 2 hours. The 
aliquots were removed from the plates and filtered through a 0.45 μm syringe filter and stored 
at 4 ºC. 
 
2.7 Bacteriophage characterization 
The bacteriophages were morphologically characterized by electron microscopy. Phage 
samples were firstly negative stained with phosphotungstic acid. Electron microscope 
photographs of the phages were taken using the FEI Tecnai G2 Spirit Transmission Electron 


















Australia, 5005). The sizes of the heads and tails of the phages were estimated by the gridding 
and scales on the microscope reading screen. 
Genomic extraction of the phages was performed following the same methods of Vinod et al. 
(2006). Briefly, phages were precipitated with 2M ZnCl2 at ratio of 1:50, and then the pellet 
was suspended in 20 μl of TENS buffer (50 mM Tris pH 8.0, 100mM EDTA, 100 mM NaCl, 
0.3% SDS) and proteinase K (100 μgmL
-1
 final concentration) and then incubated at 65 °C 
for 10 min. Proteins were removed by two phenol/chloroform/isoamyl alcohol (Sigma-
Aldrich) extractions and the nucleic acid was precipitated with isopropanol. The pellets were 
suspended in TE buffer (10 mM Tris, 1mM EDTA, pH 8.0) after washing in 70% ethanol.  
The phage genomic material was digested with enzymes S1 nuclease (Thermo Scientific), 
BamHI restriction endonuclease (Thermo Scientific), and RNase A (Thermo Scientific) 
separately. The procedures were performed following the manufacturer’s instructions. After 
digestion, bands were separated by electrophoresis on 0.75% agarose gels at 100 V for 1 hour. 




Once the phage isolates were purified following three rounds of isolation, the genomes were 
sequenced by next generation sequencing.  Library preparation for next-generation 
sequencing was performed using the Nextera XT DNA kit (Illumina) according to the 
manufacturer’s instructions.  Each sample was tagged with a separate index and all four 
samples were then pooled and sequenced on an Illumina MiSeq using a V2 2x250 reagent kit 
and standard Illumina protocols. The identified phages were named following the 
methodology proposed by Kropinski et al. (2009). 
 
2.8 Phage specificity 
Phage specificity was tested by drop-spots plaque assay. All bacterial isolates were used to 


















phage stock onto different isolate lawns, and incubated at 28 °C overnight. Visual 
examination for the presence of plaques was conducted the following day. 
 
2.9 Phage lytic ability 
The ability of the bacteriophage to lyse the bacterial cells was determined in an in vitro dose 
dependent assay. Bacterial isolates were grown to an O.D. of approximately 0.5, which was 




, and mixed with different concentrations of phage. 
Individual phages were prepared by the same method as for phage passage, but were stored in 
PYSS broth. Titers were performed to confirm the concentration of each phage. 
The effective dose of the phage in the in vitro test was determined in a 96-well plate assay. 




. Diluted aliquots 
(200 µL) were mixed with an equal volume of pre-grown bacterial culture. Each aliquot was 
replicated in triplicate; and blank wells were filled with the mixture of equal volume of PYSS 
broth and bacterial culture. Growth curves were generated by measuring the O.D. at A600 of 
each well every 5 min for 18 hours (BIO-RAD xMark™ Microplate Spectrophotometer SW 
MPM6), with shaking for 30 seconds prior to each reading.  
 
2.10 Abalone bioassay 
One hundred and twenty abalones were divided into four challenge groups. Each group was 
divided into 3 subgroups, resulting in the experiment being performed in triplicate. The 





 for 4 hours followed by 2 hours of PYSS broth exposure), a negative control group 
(PYSS broth for 6 hours), a phage control (4 hours of PYSS broth followed by 2 hours of 




), and a phage treated group (same bacteria 
exposure as the positive control for 4 hours, followed by phage exposure of 2 hours similar to 
phage control group). After each exposure, the abalones were washed with natural seawater. V. 






















seawater filled containers holding the abalone. The dilution factor resulted in the abalone 




 of strain MO10. The mortality rate for each replicate was 
recorded daily for 7 days post exposure. 
 
2.11 Data analysis 
Prophage determination and in vitro assay were analyzed by observation of the bacterial 
growth profile using an optical density at an absorbance of 600 nm. Plaques were assessed by 
visualization for phage isolation and the host specificity test. Characterisation and 
identification of the phages were done by using Transmission Electron Microscopy (TEM) 
images and genomic digestion analysis. SPSS was used to analyze the differences between 
treatment groups by ANOVA and post-hoc tests. 
For next generation sequencing analysis, MiSeq reads were imported into CLC Genomics 
Workbench (Qiagen) and de novo assembly of genomes undertaken before performing an 
NCBI BLAST search. 
 
3 Results 
3.1 Prophage detection in bacterial collection 
Optical density curves from the MMC assay indicated that there were no prophages in the 
Vibrio harveyi strains used in the subsequent experiments, as there was no changes in the 
growth curves for all bacterial strains (results not shown) compared to the controls. No 
prophage induction was indicated by optical measurements of MMC treated cultures. 
 
3.2 Bacteriophage identification  
 
Two bacteriophages in total were isolated and named vB_VhaS-a and vB_VhaS-tm following 
recommended bacteriophage nomenclature. vB_VhaS-a was from water sample and tm 
following recommended bacteriophage nomenclature. vB_VhaS-a was from water sample 


















microscope (TEM) images demonstrated that the isolated phages were non-enveloped viruses 
with icosahedral heads and long non-contractile tails (Fig. 1). The head diameters were 
between 40 nm to 90 nm. The morphological features of these phages were consistent with 
phages in the family Siphoviridae (Murphy 1995). Phage vB_VhaS-a has a genome length of 
approximately 82 Kb (Genbank accession number KX198614 in); while phage vB_VhaS-tm 
has a genome length of approximately 59 Kb (Genbank accession number KX198615). 
BLAST analysis indicated Phage vB_VhaS-a shares most similarity to Vibrio phage SIO-2 
(Genbank accession number HQ316604) with an identity of 74% over a coverage of 69%, and 
phage vB_VhaS-tm shares most similarity to Vibrio phage VpKK5 (KM378617) with an 



















3.3 Genomic digestion and electrophoresis 
S1 nuclease, RNase A, and BamHI endonuclease digestion did not result in any cut or 
degraded genomic material which was smaller than 10kb (results not shown). S1 nuclease 
specifically cuts single stranded nucleic acids (both DNA and RNA), and as S1 nuclease 
failed to digest the material, the results suggested that these phages were most likely double 
stranded. RNase A degrades single stranded and double stranded RNA. As RNase A also 
failed to digest the genetic material, the results suggested the two selected phages were double 
stranded DNA phages. Further restriction enzyme digestion with BamHI did not produce 
DNA bands that could be sized below the highest molecular marker of 10kb. The results 
indicated that the genome size of these two phages were above 10Kb. 
 
Using the combined results from the TEM imaging, the digestions and genomic sequencing, 
selected phages were confirmed to be species within the Siphoviridae family, in the order 
Caudovirales. 
 
3.4 Phage specificity test 
The two phages had the ability to lyse the bacteria as indicated by the plaques formed on lawn 
plates (Table. 1).  
 
3.5 Dose Response of Bacteriophage Therapy in vitro 
The growth curves of MO10 and MO10WS were determined after treatment with individual 
phages and a cocktail of the 2 phages with different titer (Figures 2 & 3). For both bacterial 
strains, only one phage showed lytic ability towards that strain.  
For bacterial strain MO10, the phage vB_VhaS-tm showed the highest inhibition of the 
bacterial growth compared with the other phage and the cocktail. After 8 hours of treatment, 


















untreated control. Phage vB_VhaS-a and the cocktail showed a similar pattern of reduced 
bacterial growth at the beginning of the assay. However, the bacteria growth only decreased 




, phage vB_VhaS-tm 
caused a decline of the bacterial growth rate and this remained at a relatively low level. 
For the bacterial strain MO10WS, the vB_VhaS-tm phage demonstrated the least effect on 
bacterial growth. Phages vB_VhaS-a and the cocktail exhibited similar patterns against 
MO10WS. The most concentrated dilution of the phage inhibited the bacterial growth most 
effectively. However, with other titres, the bacterial growth increased then decreased, only to 
later increase until the end of the experiment. 
Comparing the results between the bacterial strains MO10 and MO10WS, MO10 strain 
showed different characteristics from MO10WS strain. Phage vB_VhaS-tm worked more 
efficiently on MO10 strain, while vB_VhaS-a showed same virulence towards both strains. 
This is an interesting finding as they are originally the same isolate. MO10 is a laboratory-
adapted strain, while MO10WS is the wild type strain, which has not been passaged in culture 
media. In this study, the cocktail of phages did not work more efficiently than any of the 
single phage treatments.  
 
3.6 Abalone bioassay 
The phage and broth control groups had no measurable effects on abalone survival. The 
survival rate in these two groups was significantly different from the positive bacterial control 
group (P≤0.001) and the bacteria challenged phage treated group (P=0.008). There was a 
significant difference between the positive bacterial control group and the phage treated group 
(P≤0.001). The accumulative survival of the phage treated group was 70%, compared to the 
positive bacterial control group of 0% survival. Most of the animals died between days 2 to 4 
post infection (Fig. 4). The accumulative survival for the phage treated group tended to be 



















This study aimed to establish an alternative treatment for vibriosis as a replacement to 
antibiotics in abalone production systems. A single phage, vB_VhaS-tm, was identified as 
most efficient in reducing the density of Vibrio harveyi isolate MO10, which was then 
selected as the trial phage for the bioassay. In the abalone challenge model, the phage 
vB_VhaS-tm resulted in 70% accumulative survival of phage treated group compared to 0% 
accumulative survival of the positive (bacterial) control group. Additionally, the phage alone 
had no measurable negative effects on the abalone. This confirms that phage vB_VhaS-tm 
inhibits or decreases the growth of the bacteria in vitro, and could be used to control the 
bacterial disease in abalone in vivo over a 7 day period. 
The two isolated phages were classified into family Siphoviridae, by predominantly using 
morphological characteristics and next generation sequencing. These results are consistent 
with several previous studies that reported V. harveyi phages and classified them into the 
family Siphoviridae (Pasharawipas et al. 2005, Karunasagar et al. 2007, Crothers-Stomps et al. 
2010, Phumkhachorn & Rattanachaikunsopon 2010). The phages have an icosahedral head 
(with head size between 40 nm to 90 nm in diameter) with long non-contractile tails. The 
phage genomes could not be digested with S1 nuclease or RNase A, which was consistent 
with results from Phumkhachorn and Rattanachaikunsopon (2010). In their study, they 
digested the genome with both PstI and BamHI. However, our study only utilized BamHI 
enzyme, resulting in no visualisation of multiple bands from the digestion when using our 
molecular marker with a maximum size of 10kb. Even after digestion, the cut genome size 
(approximately 45 and 14 Kb respectively) was larger than the largest marker (10Kb) used in 
this study, which was confirmed by the genomic sequencing results.  Next generation 
sequencing analysis of the genomes indicates some similarity to vibrio phages deposited in 
GenBank, however the similarity and coverage levels are relatively low indicating these are 
previously uncharacterized or reported species of phage. 


















concentration increased and resulted in inhibition of the bacterial growth. Phage vB_VhaS-tm 
showed more lytic ability towards each experimental strain. It maintained the bacterial 
concentration at a low level with some form of equilibrium. This low titer showed that there’s 
great potential of using this dose for actual phage treatment. Usually, a lytic phage would 
inhibit the bacterial growth with a relatively large titer. In this study, the titer of 10
2
 pfu·mL-1 
was selected as the dose for the in vivo assay (Figures 2). A lower titer of the selected phage 
vB_VhaS-tm, was not very lytic towards V. harveyi isolate MO10. Although a higher titer 
would be associated with more lytic ability, the titer of 10
2
 pfu·mL-1 was chosen for practical 
purposes. Immersion of abalones with the original phage aliquot was impractical for the 
aquaculture system. 
When phage vB_VhaS-tm was applied at a concentration of 10
2
 pfu·mL-1 to V. harveyi 
exposed abalones, the accumulative survival of the abalones increased by 70%. These results 
demonstrated that bacteriophage therapy is effective as a treatment against V. harveyi 
infection in abalone. The exposure of the bacteria to the abalone results in rapid infection as 
adhesion and penetration of V. harveyi occurs within the first hour of contact (Cardinaud et al. 
2014a); this study used an exposure time of four hours for the bacteria to complete a full 
infection, before the treatment of the abalone with phage. The accumulative survival tended to 
be constant from day 5. This illustrated that if used early in infection; a phage therapy 
program could be used to control the onset of vibriosis. Antibiotics have been used as the 
major treatment method for vibriosis (Defoirdt et al. 2011), resulting in the emergence of 
antibiotic resistant bacteria (Defoirdt et al. 2011, Jun et al. 2014b). The in vivo test results 
support that bacteriophage therapy could be considered as an alternative solution for antibiotic 
use in terms of controlling bacterial induced diseases and reduction in the emergence of 
antibiotic resistant bacterial strains within abalone aquaculture, as stated by Yu et al. (2013).  
Successful application of phage therapy to control vibriosis has been previously demonstrated 
for both vertebrates and invertebrates (Nakai & Park 2002, Soothill et al. 2004, Karunasagar 


















& Hipólito-Morales 2013, Yu et al. 2013, Jun et al. 2014a, Jun et al. 2014b, Mateus et al. 
2014, Rong et al. 2014, Silva et al. 2014a, Silva et al. 2014b, Tiwari et al. 2014, 
Madhusudana Rao & Lalitha 2015). As a preliminary trial, our study developed a model to 
demonstrate that phage therapy can be applied to abalone to control bacterial disease. 
Additional research is required before phage therapy can be successfully applied to the 
abalone industry, for instance, determining timing and quantity of the dose. The current 
propagation methods for the phage are only suitable for generating small amount of phage, 
and a more efficient method of harvesting large amount of phage needs to be developed.  
This study is the first trial to apply phage therapy to control V. harveyi infection in abalone in 
simulated industrial conditions of high water temperature. The negative control group showed 
that even when the animals were under thermal stress, they could survive the elevated 
temperature over the 7 day period. In contrast to the negative control group, the positive 
control group that was infected with V. harveyi underwent 100% mortality within 5 days. 
Travers et al. (2008a) showed mortality occurred on the fourth day after infection at 19 °C. 
When bacterial challenged at 24 °C, death started within 24 hours. When abalones are 
exposed to high water temperature of 26 °C, there will be damage to the gill epithelium 
providing a pathway for pathogens, such as V. harveyi, to invade the animal (Lange et al. 
2014). It has been found that abalone cannot recover from this physical damage under 
elevated water temperatures (Hooper et al. 2014). Under these circumstances, abalones are 
very vulnerable to infectious pathogens such as V. harveyi. These studies indicated that 
abalones are highly susceptible to water temperature changes (Dang et al. 2012, Cardinaud et 
al. 2014b, Lange et al. 2014, Stone et al. 2014). The safety of phage therapy herein was also 
demonstrated in agreement with previous studies (Tiwari et al. 2014, Madhusudana Rao & 
Lalitha 2015). Even under thermal stress, the phage control group did not show any mortality. 
V. harveyi induced vibriosis is reported to be significantly associated with immune system 
suppression during the summer season when temperatures are above 23 °C (Handlinger et al. 


















In conclusion, this study has identified that bacteriophages can effectively inhibit the model 
bacteria V. harveyi growth in vitro and in vivo. Furthermore, this study has also demonstrated 
the effectiveness of bacteriophage therapy as a potential alternative therapy in controlling 
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Strain vB_VhaS-a vB_VhaS-tm 
MO10 + + 
 MO10WS + + 
MO67 - + 
MO68 - + 
MO69 + + 
MO70 + + 
MO71 + + 
































Fig. 1 TEM images for the selected phages, a & b = vB_VhaS-tm; and c & d = vB_VhaS-a, 
with head size between 40 nm to 90 nm, and long non-contractile tails. 
 
Fig 2. Growth curves for MO10 infected by vB_VhaS-a; vB_VhaS-m; and phage cocktail, 
with 1:10 dilution factors from 0 to 4 and bacterial PYSS broth controls for 18 hours using 
optical density as indicators. a) vB_VhaS-a; b) vB_VhaS-m. c = bacterial PYSS control, 0 = 



















Fig. 3 Growth curves for MO10WS infected by vB_VhaS-a; vB_VhaS-m; and phage cocktail, 
with 1:10 dilution factors from 0 to 4 and bacterial PYSS broth controls for 18 hours using 
optical density as indicators. a) vB_VhaS-a, b) vB_VhaS-m, c) phage cocktail. c = bacterial 



















Fig. 4 Accumulative survival of abalone for each treatment group at 24 °C for 7 days (with 
error bars for within group variances) using bacterial strain MO10 as the infectious agent, and 
treated with phage vB_VhaS-tm. n=10 for each treatment group, and triplicated for each 
treatment. Positive control = 4 hours of bacterial exposure and 2 hours of PYSS broth 
exposure; Phage treated group = 4 hours of bacterial exposure and 2 hours of phage 
vB_VhaS-tm exposure; Phage control = 4 hours of PYSS broth exposure and 2 hours of 
phage exposure; and Negative control = 4 hours of PYSS broth exposure and 2 hours of 
PYSS broth exposure. Animals were washed with natural seawater after each exposure. 
 
 
Table 1. Phage specificity test results against all experimental V. harveyi strains. (+) indicated 
plaque formation, (-) indicates there was no plaque. 
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